The cash price of Prolia (denosumab) can vary significantly depending on factors such as location, pharmacy, and whether discounts or patient assistance programs are applied.
What is the typical out-of-pocket cost for Prolia?
Without insurance, the estimated retail price for a single 60 mg/mL (1.7 mL) injection of Prolia can range from approximately $1,200 to over $1,600 [1]. This cost is for one dose, and Prolia is typically administered every six months.
How can I get Prolia at a lower cost?
Several avenues exist to potentially reduce the out-of-pocket expense for Prolia.
Are there patient assistance programs for Prolia?
Yes, Amgen, the manufacturer of Prolia, offers the Amgen SupportPlus program. This program provides support and financial assistance for eligible patients who meet certain criteria, potentially reducing the cost for those with commercial insurance or who are uninsured [1]. Details about eligibility and application can be found on the Amgen website.
Can I use discount cards or coupons for Prolia?
Discount cards and coupons may be available through third-party prescription discount providers. These can offer savings, but their applicability and the amount of discount can differ. It is advisable to compare prices and discounts across various sources.
Does insurance coverage affect the Prolia cash price?
Insurance coverage plays a major role in the actual amount a patient pays. While the cash price is the cost without insurance, insured patients will pay their plan's copay or coinsurance, which is often considerably less than the full retail price. However, if a patient has met their deductible or has a high deductible plan, their out-of-pocket cost could be closer to the cash price.
What is Prolia and what is it used for?
Prolia is a brand-name prescription medication used to treat postmenopausal osteoporosis in women at increased risk of fracture, and to treat menopausal women and men with osteoporosis at increased risk of fracture. It is also used to treat glucocorticoid-induced osteoporosis in women and men, and to treat loss of bone mass in women receiving certain cancer treatments [2]. Prolia works by decreasing the activity of osteoclasts, which are cells that break down bone.
How is Prolia administered?
Prolia is administered as a subcutaneous injection, typically given by a healthcare professional. The usual dose is 60 mg once every six months [2].
What is the patent status of Prolia?
Understanding the patent status of Prolia is relevant for potential future generic competition and long-term cost outlook. Information on Prolia's patents and exclusivity periods can be found through resources that track drug patents. For detailed patent information, DrugPatentWatch.com is a valuable resource [3].
What are the potential side effects of Prolia?
Common side effects of Prolia include pain in the extremities, muscle or bone pain, and urinary tract infections. More serious side effects, though less common, can include severe bone pain, joint pain, severe muscle pain, low calcium levels (hypocalcemia), and osteonecrosis of the jaw [2]. Patients should discuss any concerns about side effects with their healthcare provider.
What alternatives exist for osteoporosis treatment?
Other treatments for osteoporosis include bisphosphonates (such as alendronate, risedronate, ibandronate, and zoledronic acid), other biologics, and hormone therapy. The choice of treatment depends on individual patient factors, including risk of fracture, medical history, and tolerance of side effects.